Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension

Am J Respir Crit Care Med. 2015 Jul 15;192(2):254-7. doi: 10.1164/rccm.201411-2061LE.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Tacrolimus